Janice M Reichert

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Coronavirus Disease

Hodgkin Lymphoma

Epidermal Growth Factor Receptor

Top Venues

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Hélène Kaplon, Silvia Crescioli, Alicia M Chenoweth, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2023. mAbs 15 (1) (2022)
Hélène Kaplon, Silvia Crescioli, Alicia M Chenoweth, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2023. mAbs 15 (1) (2022)
Hélène Kaplon, Alicia M Chenoweth, Silvia Crescioli, Janice M Reichert
Antibodies to watch in 2022. mAbs 14 (1) (2022)
Hélène Kaplon, Silvia Crescioli, Alicia M Chenoweth, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2023. mAbs 15 (1) (2022)
Hélène Kaplon, Silvia Crescioli, Alicia M Chenoweth, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2023. mAbs 15 (1) (2022)
Hélène Kaplon, Janice M Reichert
Antibodies to watch in 2021. mAbs 13 (1) (2021)
Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider, Janice M Reichert
Antibodies to watch in 2020. mAbs 12 (1) (2021)
Aran F Labrijn, Maarten L Janmaat, Janice M Reichert, Paul W H I Parren
Bispecific antibodies: a mechanistic review of the pipeline. Nature reviews. Drug discovery 18 (8) (2020)
Hélène Kaplon, Janice M Reichert
Antibodies to watch in 2019. mAbs 11 (2) (2018)